| Community and clinical epidemiology of borderline personality disorder WD Ellison, LK Rosenstein, TA Morgan, M Zimmerman Psychiatric Clinics 41 (4), 561-573, 2018 | 277 | 2018 |
| The clinical significance of single features of borderline personality disorder: Anger, affective instability, impulsivity, and chronic emptiness in psychiatric outpatients WD Ellison, L Rosenstein, I Chelminski, K Dalrymple, M Zimmerman Journal of personality disorders 30 (2), 261-270, 2016 | 132 | 2016 |
| Narcissistic personality disorder KN Levy, LK Rosenstein The Wiley Encyclopedia of Personality and Individual Differences: Clinical …, 2020 | 95 | 2020 |
| Have treatment studies of depression become even less generalizable? A review of the inclusion and exclusion criteria used in placebo-controlled antidepressant efficacy trials … M Zimmerman, HL Clark, MD Multach, E Walsh, LK Rosenstein, ... Mayo Clinic Proceedings 90 (9), 1180-1186, 2015 | 83 | 2015 |
| The role of emotion regulation difficulties in the connection between childhood emotional abuse and borderline personality features. LK Rosenstein, WD Ellison, E Walsh, I Chelminski, K Dalrymple, ... Personality Disorders: Theory, Research, and Treatment 9 (6), 590, 2018 | 65 | 2018 |
| A Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive Disorder M Zimmerman, I Chelminski, D Young, K Dalrymple, E Walsh, ... The Journal of clinical psychiatry 75 (6), 2829, 2014 | 53 | 2014 |
| Comorbid bipolar disorder and borderline personality disorder and substance use disorder D Hidalgo-Mazzei, E Walsh, L Rosenstein, M Zimmerman The Journal of nervous and mental disease 203 (1), 54-57, 2015 | 35 | 2015 |
| Body mass index, depression, and suicidality: The role of self-esteem in bariatric surgery candidates M Yusufov, K Dalrymple, MH Bernstein, E Walsh, L Rosenstein, ... Journal of affective disorders 208, 238-247, 2017 | 33 | 2017 |
| Principal diagnoses in psychiatric outpatients with borderline personality disorder: Implications for screening recommendations. M Zimmerman, I Chelminski, K Dalrymple, L Rosenstein Annals of clinical psychiatry: Official journal of the American Academy of …, 2017 | 24 | 2017 |
| The association between mentalizing and psychopathology: A meta-analysis of the reading the mind in the eyes task across psychiatric disorders. BN Johnson, Y Kivity, LK Rosenstein, JM LeBreton, KN Levy Clinical Psychology: Science and Practice 29 (4), 423, 2022 | 22 | 2022 |
| The importance of assessing for childhood abuse and lifetime PTSD in bariatric surgery candidates E Walsh, L Rosenstein, K Dalrymple, I Chelminski, M Zimmerman Journal of clinical psychology in medical settings 24, 341-354, 2017 | 19 | 2017 |
| Symptom severity and the generalizability of antidepressant efficacy trials: changes during the past 20 years M Zimmerman, HL Clark, MD Multach, E Walsh, LK Rosenstein, ... Journal of clinical psychopharmacology 36 (2), 153-156, 2016 | 15 | 2016 |
| Psychotherapy for personality disorders BN Johnson, TL Clouthier, LK Rosenstein, KN Levy Encyclopedia of personality and individual differences, 4216-4234, 2020 | 13 | 2020 |
| Transference-focused psychotherapy (TFP) KN Levy, N Draijer, Y Kivity, FE Yeomans, LK Rosenstein Current treatment options in psychiatry 6, 312-324, 2019 | 10 | 2019 |
| Modification of the medical exclusion criterion in DSM-5 social anxiety disorder: Comorbid obesity as an example KL Dalrymple, E Walsh, L Rosenstein, I Chelminski, M Zimmerman Journal of affective disorders 210, 230-236, 2017 | 9 | 2017 |
| The psychiatric inclusion and exclusion criteria in placebo-controlled monotherapy trials of bipolar depression: an analysis of studies of the past 20 years M Zimmerman, CG Holst, HL Clark, M Multach, E Walsh, LK Rosenstein, ... CNS drugs 30, 1209-1218, 2016 | 9 | 2016 |
| Problems in the descriptions of the psychiatric inclusion and exclusion criteria in publications of antidepressant efficacy trials: a qualitative review and recommendations for … M Zimmerman, M Multach, E Walsh, LK Rosenstein, D Gazarian, HL Clark CNS drugs 30, 185-191, 2016 | 9 | 2016 |
| Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling M Zimmerman, HL Clark, MD Multach, E Walsh, LK Rosenstein, ... Journal of Affective Disorders 190, 357-361, 2016 | 8 | 2016 |
| Inclusion/exclusion criteria in late life depression antidepressant efficacy trials M Zimmerman, MD Multach, HL Clark, E Walsh, LK Rosenstein, ... International Journal of Geriatric Psychiatry 32 (9), 1009-1016, 2017 | 5 | 2017 |
| Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials M Zimmerman, HL Clark, MD Multach, E Walsh, LK Rosenstein, ... Journal of Affective Disorders 198, 39-42, 2016 | 5 | 2016 |
